255 related articles for article (PubMed ID: 16966157)
1. Biomarkers in cancer screening, research and detection: present and future: a review.
Kumar S; Mohan A; Guleria R
Biomarkers; 2006; 11(5):385-405. PubMed ID: 16966157
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of cancer risk and therapeutic benefit: new technologies, new opportunities, and some challenges.
MacGregor JT
Toxicol Pathol; 2004; 32 Suppl 1():99-105. PubMed ID: 15209409
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers: potential uses and limitations.
Mayeux R
NeuroRx; 2004 Apr; 1(2):182-8. PubMed ID: 15717018
[TBL] [Abstract][Full Text] [Related]
4. Proteomics biomarkers for solid tumors: Current status and future prospects.
Belczacka I; Latosinska A; Metzger J; Marx D; Vlahou A; Mischak H; Frantzi M
Mass Spectrom Rev; 2019 Jan; 38(1):49-78. PubMed ID: 29889308
[TBL] [Abstract][Full Text] [Related]
5. Proteomics of cancer of hormone-dependent tissues.
Tyson DR; Ornstein DK
Adv Exp Med Biol; 2008; 630():133-47. PubMed ID: 18637489
[TBL] [Abstract][Full Text] [Related]
6. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
7. Unlocking the potential of oncology biomarkers: advancements in clinical theranostics.
Dubey AK; Kaur I; Madaan R; Raheja S; Bala R; Garg M; Kumar S; Lather V; Mittal V; Pandita D; Gundamaraju R; Singla RK; Sharma R
Drug Metab Pers Ther; 2024 Mar; 39(1):5-20. PubMed ID: 38469723
[TBL] [Abstract][Full Text] [Related]
8. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.
Mohri Y; Toiyama Y; Kusunoki M
Expert Rev Proteomics; 2016 Dec; 13(12):1131-1139. PubMed ID: 27744719
[TBL] [Abstract][Full Text] [Related]
9. Cancer Proteomics and the Elusive Diagnostic Biomarkers.
Bradshaw RA; Hondermarck H; Rodriguez H
Proteomics; 2019 Nov; 19(21-22):e1800445. PubMed ID: 31172665
[TBL] [Abstract][Full Text] [Related]
10. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
Srivastava A; Creek DJ
Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
[TBL] [Abstract][Full Text] [Related]
11. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers.
Verma M; Wright GL; Hanash SM; Gopal-Srivastava R; Srivastava S
Ann N Y Acad Sci; 2001 Sep; 945():103-15. PubMed ID: 11708463
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and Predictive Biomarkers in Cancer.
Nair M; Sandhu SS; Sharma AK
Curr Cancer Drug Targets; 2014; 14(5):477-504. PubMed ID: 24807144
[TBL] [Abstract][Full Text] [Related]
13. Biomarker research with prospective study designs for the early detection of cancer.
Pesch B; Brüning T; Johnen G; Casjens S; Bonberg N; Taeger D; Müller A; Weber DG; Behrens T
Biochim Biophys Acta; 2014 May; 1844(5):874-83. PubMed ID: 24361552
[TBL] [Abstract][Full Text] [Related]
14. Peptides in body fluids and tissues as markers of disease.
Schulte I; Tammen H; Selle H; Schulz-Knappe P
Expert Rev Mol Diagn; 2005 Mar; 5(2):145-57. PubMed ID: 15833045
[TBL] [Abstract][Full Text] [Related]
15. The identification of human tumour antigens: Current status and future developments.
Miles AK; Matharoo-Ball B; Li G; Ahmad M; Rees RC
Cancer Immunol Immunother; 2006 Aug; 55(8):996-1003. PubMed ID: 16408215
[TBL] [Abstract][Full Text] [Related]
16. Novel approaches to identification of biomarkers for detection of early stage cancer.
Kiviat NB; Critchlow CW
Dis Markers; 2002; 18(2):73-81. PubMed ID: 12364813
[TBL] [Abstract][Full Text] [Related]
17. Genomic and proteomic biomarkers for cancer: a multitude of opportunities.
Tainsky MA
Biochim Biophys Acta; 2009 Dec; 1796(2):176-93. PubMed ID: 19406210
[TBL] [Abstract][Full Text] [Related]
18. Role of Salivary Biomarkers in Oral Cancer Detection.
Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
[TBL] [Abstract][Full Text] [Related]
19. Proteomics: new technologies and clinical applications.
Latterich M; Abramovitz M; Leyland-Jones B
Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
[TBL] [Abstract][Full Text] [Related]
20. Contribution of oncoproteomics to cancer biomarker discovery.
Cho WC
Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
